NCT05050656View on ClinicalTrials.gov

Oral Duloxetine as a Premedication for Postoperative Pain Control

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

March 15, 2021

Primary Completion Date

July 28, 2021

Study Completion Date

July 29, 2021

Conditions
Anesthesia
Interventions
DRUG

Duloxetine 60mg

Duloxetine is a selective SNRI prescribed in depression, anxiety, and chronic pain like diabetic neuropathy and fibromyalgia, it acts through central and peripheral pain modulation

DRUG

Placebo

placebo tablets identical to duloxetine tablets

Trial Locations (1)

11591

faculty of medicine, Ain Shams University, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT05050656 - Oral Duloxetine as a Premedication for Postoperative Pain Control | Biotech Hunter | Biotech Hunter